Cellnovo secures GBP30m in Series B financing
Cellnovo, developer of the first mobile diabetes management system, has raised GBP30 million (USD48.4 million) in a Series B financing round led by Edmond de Rothschild Investment Partners (EdRIP), with Forbion Capital Partners; Auriga Partners; NBGI Ventures and Credit Agricole Private Equity, joining Series A investors Advent Venture Partners, HealthCare
